IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q3 2016 Holdings

Filed 2016-11-10 | 20 holdings | $57.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
PTC Therapeutics(PTCT)COM69366J200$8.0K567,68313.8%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$5.7K150,6519.9%
Bio-Rad LabratoriesCOM90572207$5.0K30,6878.7%
Amicus Therapeutics Inc(FOLD)COM03152W109$4.6K618,3178.0%
Centene Corp(CNC)COM15135B101$4.5K67,8567.9%
Impax Laboratories IncCOM45256B101$3.9K164,1566.8%
Unitedhealth Group Inc(UNH)COM91324P102$3.9K27,7286.8%
Incyte Corp(INCY)COM45337C102$3.5K37,4076.1%
Jazz Pharmaceuticals(JAZZ)COMG50871105$3.4K28,2296.0%
ELI Lilly & Co(LLY)COM532457108$2.7K33,0294.6%
Ironwood PharmaceuticalsCOM4633X108$2.4K149,7204.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$1.9K37,6443.3%
Synergy Pharmaceuticals IncCOM871639308$1.9K339,0683.2%
Edwards Lifesciences Corp(EW)COM28176E108$1.7K13,9082.9%
Novocure LTDCOMBYSS4X4$1.3K157,1762.3%
Nevro Corp(NVROEUR)COM64157F103$1.3K12,1612.2%
Flamel TechnologiesADR2351397$71657,7691.2%
Galapagos NVADRB292NQ7$4046,2500.7%
Quest DiagnosticsCOM2702791$3984,7000.7%
Glaukos CorpCOMBYMWL19$38610,2330.7%